
Enforcement of rules to encourage the freer flow of healthcare data were delayed because of the COVID-19 pandemic. They are now scheduled to go into effect this year.

Enforcement of rules to encourage the freer flow of healthcare data were delayed because of the COVID-19 pandemic. They are now scheduled to go into effect this year.

A survey conducted by Nationwide Retirement Institute® highlights the challenges Black caregivers overcome during COVID-19.


Many moms-to-be are searching for new remote pregnancy monitoring solutions and some tips and facts for those expecting and for prenatal care organizations are included below.

Peter Wehrwein, senior editor of Managed Healthcare Executive, speaks with Mohan Giridharadas, the founder and CEO at LeanTaas, a software and machine learning company. The Santa Clara, California, company’s software enables healthcare systems to maximize efficient use of their infusion centers, operating rooms and other facilities. More efficient use translates into improved access to services for patients, especially during the COVID-19 pandemic, Giridharadas explains.

Insight into people’s irrational choices can improve healthcare.

Young adults, in particular, are more likely to seek out and place high value on telemedicine for eye care and those in vulnerable populations are benefitting most, according to an annual vision wellness study by VersantHealth.

The Next Generation ACO program, was supposed to end in 2020, but it was granted a one-year reprieve because of the COVID-19 pandemic. The National Association of ACOs (NAACOS) wants that extension to become permanent and says the “Next Gen” ACOs save the Medicare program a lot of money. Former CMS Administrator Seema Verma begs to differ.

As distribution of the COVID-19 vaccines sputters along, this question will be asked: Should people who are immunocompromised get vaccinated?


Deloitte health report projects a deceleration in health spending, likely creating a U.S. $3.5 trillion “well-being dividend” by 2040. The report shares what the future of health could look like: new business models, emerging technologies, and highly engaged consumers.

One of the new treatments available is a CAR-T cell therapy to treat relapsed or refractory large B-cell lymphoma.

MHE's Briana Contreras spoke with Bill Coletti, CEO, and Founder of Kith, a firm serving organizations in communication crisis and reputation management, in this week's episode of Tuning In to the C-Suite. Bill and Briana discussed how working with healthcare leaders during a crisis has changed since the COVID-19 pandemic, how leaders in the C-Suite can be prepared for a crisis and what to do in the journey post-crisis.

Diabetes education has shifted from in-person classes to Zoom meetings.

Population immunity is required in order to beat COVID-19. According to an opinion piece by Michael Criqui and Robert M. Kaplan on NPR, a quicker end to the pandemic requires two policy changes: delaying inoculation of those with prior COVID-19 infections, and temporarily widening the interval between the vaccine doses.

Preliminary results from a safety clinical trial show an increased risk of serious heart-related problems and cancer with the rheumatoid arthritis and ulcerative colitis medicine Xeljanz.

Payer strains now top the list of stressors facing oncologists, with prior authorization as the most-cited source of that payer stress.

The COPD Foundation is calling for a change in clinical trial design that would test experimental therapies in subsets of patients.

Employees of Kroger Co. who receive a COVID-19 vaccine will be rewarded with a $100 bonus, according to the supermarket giant.

Mobile Healthcare Services has launched in Massachusetts, offering a variety of customized COVID-19 testing program options and conducting more than 30,000 mobile COVID-19 tests per month to help mitigate the spread of the novel coronavirus.

Johnson & Johnson formally requested an emergency use authorization for its one-dose vaccine, AstraZeneca reports data that show its vaccine is protective against the B.1.1.7 variant and other COVID-19 vaccine news last week.

Johnson & Johnson submitted its single-shot COVID-19 vaccine to U.S. regulators recently for emergency use authorization after the vaccine was shown to be effective against illness and preventing severe disease and death.

Dorit Rubinstein Reiss and Arthur L. Caplan contributed a recent editorial to Health Affairs discussing how healthcare workers with temporary, unpleasant side effect from COVID-19 vaccines deserve appropriate time off without having to use up their regular sick leave or paid time off.

The move to put Witty in charge of the healthcare giant is described as "abrupt."

She helped launch the ACA as a top Obama administration official.

Based on results of the VISION study, the FDA has granted accelerated approval to tepotinib for MET exon 14 skipping altered metastatic non–small cell lung cancer.

Greater investment in AI and data security are among the keys.

Costs for electronic processing have decreased as costs for manual and partially electronic transactions have increased, resulting in opportunities to save $16.3 billion in the future.

In this episode of Tuning In to the C-Suite, MHE Associate Editor Briana Contreras spoke with Associate Dean for Equity Inclusion and Research Professor in the College of Nursing at Penn State University, Dr. Sheldon Fields. He is also the first Vice President for the National Black Nurses Association. In celebration of Black History Month, the two discussed racial equity in healthcare and what is being done for patients and nurses of color toward the improvement of the racial and health disparities that take place in care.
